Erin L. Winstanley - Concepedia

Author

Erin L. Winstanley

University of Cincinnati Medical Center ORCID

Also Known As

E.L. Winstanley, ERIN L. WINSTANLEY, Erin L. Winstanley, Erin L Winstanley, Erin L. Winstanley, Erin Winstanley, Winstanley, Erin

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Cincinnati Medical Center West Virginia University Lindner Center of HOPE Johns Hopkins University Blanchette Rockefeller Neurosciences Institute

About

Erin L. Winstanley is an author at University of Cincinnati Medical Center specializing in medicine, substance abuse, and addiction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	843
2	Health Sciences	12	12	679
3	Public Health	7	7	437
4	Education	2	2	218
5	Nursing	1	1	52

Erin L. Winstanley

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Emergency Department Prescription Opioids as an Initial Exposure Preceding Addiction Megan M. Butler, Rachel M. Ancona, Gillian A. Beauchamp, Annals of Emergency Medicine Substance AbuseSubstance UsePsychiatryAddiction TreatmentAddiction	2016	183
The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment Erin L. Winstanley, Donald M. Steinwachs, Margaret E. Ensminger, Drug and Alcohol Dependence Substance AbuseSubstance UseAlcohol DependenceAddictionJuvenile Delinquency	2007	180
The Impact of the Opioid Epidemic on Children and Adolescents Erin L. Winstanley, Amanda N. Stover Clinical Therapeutics Opioid EpidemicSubstance AbuseSubstance UseAdolescent MedicineAddiction	2019	95
Moving Beyond Misuse and Diversion: The Urgent Need to Consider the Role of Iatrogenic Addiction in the Current Opioid Epidemic Gillian A. Beauchamp, Erin L. Winstanley, Shawn A. Ryan, American Journal of Public Health Opioid EpidemicSubstance UsePsychopathologyDrug TreatmentHarm Reduction	2014	91
Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case‐series and feasibility Marc Fishman, Erin L. Winstanley, Erin M. Curran, Addiction	2010	85
Using digital technologies in clinical trials: Current and future applications Carmen La Rosa, Lisa A. Marsch, Erin L. Winstanley, Contemporary Clinical Trials Clinical Trial DesignDigital HealthClinical TrialsRandomized Controlled TrialPublic Health	2020	84
Duloxetine in the treatment of binge eating disorder with depressive disorders: A placebo‐controlled trial Anna I. Guerdjikova, Susan L. McElroy, Erin L. Winstanley, International Journal of Eating Disorders	2011	82
Barriers to Implementation of Opioid Overdose Prevention Programs in Ohio Erin L. Winstanley, Angela Clark, Judith Feinberg, Substance Abuse	2015	72
Strategies and policies to address the opioid epidemic: A case study of Ohio Jonathan Penm, Neil J. MacKinnon, Jill Boone, Journal of the American Pharmacists Association	2017	72
A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance Susan L. McElroy, Erin L. Winstanley, Brian Martens, International Clinical Psychopharmacology	2010	67

Page 1